Cargando…

Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography–mass spectrometry

The crystallizable fragment (Fc) of immunoglobulin G (IgG) activates key immunological responses by interacting with Fc gamma receptors (FcɣR). FcɣRIIIb contributes to neutrophil activation and is involved in antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lippold, Steffen, Knaupp, Alexander, de Ru, Arnoud H., Tjokrodirijo, Rayman T. N., van Veelen, Peter A., van Puijenbroek, Erwin, de Taeye, Steven W., Reusch, Dietmar, Vidarsson, Gestur, Wuhrer, Manfred, Schlothauer, Tilman, Falck, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726612/ https://www.ncbi.nlm.nih.gov/pubmed/34674601 http://dx.doi.org/10.1080/19420862.2021.1982847

Ejemplares similares

Affinity capillary electrophoresis – mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner
por: Gstöttner, Christoph, et al.
Publicado: (2022)

Affinity Capillary Electrophoresis–Mass Spectrometry as a Tool to Unravel Proteoform-Specific Antibody–Receptor Interactions
por: Gstöttner, Christoph, et al.
Publicado: (2021)

Function-structure approach reveals novel insights on the interplay of Immunoglobulin G 1 proteoforms and Fc gamma receptor IIa allotypes
por: Lippold, Steffen, et al.
Publicado: (2023)

Site-Specific Glycosylation Mapping of Fc Gamma Receptor IIIb from Neutrophils of Individual Healthy Donors
por: Wojcik, Iwona, et al.
Publicado: (2020)

Proteoform-Resolved FcɤRIIIa Binding Assay for Fab Glycosylated Monoclonal Antibodies Achieved by Affinity Chromatography Mass Spectrometry of Fc Moieties
por: Lippold, Steffen, et al.
Publicado: (2019)

Glycoform-resolved FcɣRIIIa affinity chromatography–mass spectrometry
por: Lippold, Steffen, et al.
Publicado: (2019)

MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation
por: Sénard, Thomas, et al.
Publicado: (2020)

FcγR Binding and ADCC Activity of Human IgG Allotypes
por: de Taeye, Steven W., et al.
Publicado: (2020)

Antigen physiochemical properties allosterically effect the IgG Fc-region and Fc neonatal receptor affinity
por: Sun, Yue, et al.
Publicado: (2020)

In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity
por: Thomann, Marco, et al.
Publicado: (2015)

Oxonium Ion Guided Analysis of Quantitative Proteomics Data Reveals Site-Specific O-Glycosylation of Anterior Gradient Protein 2 (AGR2)
por: Pirro, Martina, et al.
Publicado: (2021)

Editorial: Roles of Fc Receptors in Disease and Therapy
por: Ganesan, Latha P., et al.
Publicado: (2020)

The Ligands for Human IgG and Their Effector Functions
por: de Taeye, Steven W., et al.
Publicado: (2019)

Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G
por: Einarsdottir, Helga K., et al.
Publicado: (2012)

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
por: Sonneveld, Myrthe E., et al.
Publicado: (2018)

N-Glycoproteins Have a Major Role in MGL Binding to Colorectal Cancer Cell Lines: Associations with Overall Proteome Diversity
por: Pirro, Martina, et al.
Publicado: (2020)

IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia
por: Schmidt, David E., et al.
Publicado: (2020)

Antibody glycosylation in COVID-19
por: Pongracz, Tamas, et al.
Publicado: (2022)

Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors
por: Crowley, Andrew R., et al.
Publicado: (2021)

Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice
por: Braster, Rens, et al.
Publicado: (2021)

Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 2: Mass spectrometric methods
por: Reusch, Dietmar, et al.
Publicado: (2015)

Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans
por: Dekkers, Gillian, et al.
Publicado: (2016)

Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation
por: Sonneveld, Myrthe E., et al.
Publicado: (2017)

Affinity purification of erythropoietin from cell culture supernatant combined with MALDI-TOF-MS analysis of erythropoietin N-glycosylation
por: Falck, David, et al.
Publicado: (2017)

Semiautomated glycoproteomics data analysis workflow for maximized glycopeptide identification and reliable quantification
por: Lippold, Steffen, et al.
Publicado: (2020)

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn
por: Kapur, Rick, et al.
Publicado: (2014)

The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement
por: Brinkhaus, Maximilian, et al.
Publicado: (2022)

Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
por: Dashivets, Tetyana, et al.
Publicado: (2015)

Serum and Plasma Immunoglobulin G Fc N-Glycosylation Is Stable during Storage
por: Amez Martín, Manuela, et al.
Publicado: (2021)

Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19
por: Pongracz, Tamas, et al.
Publicado: (2022)

Human IgE does not bind to human FcRn
por: Brinkhaus, Maximilian, et al.
Publicado: (2022)

Fc Gamma Receptor IIIB (FcγRIIIB) Polymorphisms Are Associated with Clinical Malaria in Ghanaian Children
por: Adu, Bright, et al.
Publicado: (2012)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
por: Schriek, Angela I., et al.
Publicado: (2022)

PROTEOFORMER 2.0: Further Developments in the Ribosome Profiling-assisted Proteogenomic Hunt for New Proteoforms
por: Verbruggen, Steven, et al.
Publicado: (2019)

Fc glycans of therapeutic antibodies as critical quality attributes
por: Reusch, Dietmar, et al.
Publicado: (2015)

Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice
por: Braster, Rens, et al.
Publicado: (2017)

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains
por: Abendstein, Leoni, et al.
Publicado: (2023)

Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies
por: Dashivets, Tetyana, et al.
Publicado: (2016)

Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions
por: van Osch, Thijs L. J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qibj78npp69o0p4ggnlnmclu6e